Novartis Investigative Site

Portalegre 7300-853

0 studies enrolling now · 1 studies all time

What they study most

Chronic Heart Failure With Reduced Ejection Fraction

Studies at this site

• Safety and Tolerability During Open-label Treatment With LCZ696 in Patients With CHF and Reduced Ejection Fraction — Completed